Phytochemical profile and therapeutic potential of Viscum album L.

References

• Abdel-Salam OM, Sleem AA, Shaffie NM. 2010. Effect of Viscum album on acute hepatic damage caused by carbon tetrachloride in rats. Turk J Med Sci. 40:421–426.
   Web of Science ®Google Scholar
• Adaramoye O, Amanlou M, Habibi-Rezaei M, Pasalar P, A. 2012. Methanolic extract of African mistletoe (Viscum album) improves carbohydrate metabolism and hyperlipidemia in streptozotocin-induced diabetic rats. Asian Pac J Trop Med. 5(6):427–433. doi:10.1016/S1995-7645(12)60073-X.
   PubMed Web of Science ®Google Scholar
• Amer B, Juvik OJ, Dupont F, Francis GW, Fossen T. 2012. Novel aminoalkaloids from European mistletoe (Viscum album L.). Phytochem Lett. 5(3):677–681. doi:10.1016/j.phytol.2012.07.005.
   Web of Science ®Google Scholar
• Amer B, Juvik OJ, Francis GW, Fossen T. 2013. Novel GHB-derived natural products from European mistletoe (Viscum album). Pharm Biol. 51(8):981–986. doi:10.3109/13880209.2013.773520.
   PubMed Web of Science ®Google Scholar
• APweb – Angiosperm Phylogeny Website, version 13. 2013. Santalales; [cited 2014 May 9]. Available from: http://www.mobot.org/MOBOT/research/APweb/.
   Google Scholar
• Arda N, Önay E, Koz Ö, Kirmizigül S. 2003. Monosaccharides and polyols from mistletoes (Viscum album L.) growing on two different host species. Biol Bratislava. 58:1037–1041.
   Web of Science ®Google Scholar
• Ball PW. 1993. Loranthaceae. In: Tutin TG, Burges NA, Chater AO, Edmondson JR, Heywood VI, Moore DM, Valentine DH, Walters SM, Webb DA, editors. Flora Europaea. Vol. 1. Cambridge: Cambridge University Press; p. 86.
   Google Scholar
• Barney W, Hawksworth FG, Geils BW. 1998. Hosts of Viscum album. Eur J For Pathol. 28(3):187–208. doi:10.1111/j.1439-0329.1998.tb01249.x.
   Web of Science ®Google Scholar
• Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B. 2004. Efficacy and safety of long-term complementary treatment with standardized European Mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncological therapy in patients with primary non-metastatic breast cancer. Drug Res. 54:456–466.
   PubMed Web of Science ®Google Scholar
• Büssing A. 1997. Mistletoe therapy and immunological research. Anti-Cancer Drugs. 8(Suppl. 1):S65.
   PubMed Web of Science ®Google Scholar
• Büssing A. 2004. Introduction: history of mistletoe uses. In: Büssing A, editor. Mistletoe. The genus Viscum. Amsterdam: Taylor & Francis e-Library; p. 1–6.
   Google Scholar
• Büssing A, Multani AS, Pathak S, Pfüller U, Schietzel M. 1998. Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. Cancer Lett. 130:57–68.
   PubMed Web of Science ®Google Scholar
• Ćebović T, Spasić S, Popović M. 2008. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo. Phytother Res. 22(8):1097–1103. doi:10.1002/ptr.2464.
   Google Scholar
• Choudhary MI, Maher S, Begum A, Abbaskhan A, Ali S, Khan A, Shafique-ur-Rehman, Atta-ur-Rahman. 2010. Characterization and antiglycation activity of phenolic constituents from Viscum album (European mistletoe). Chem Pharm Bull. 58(7):980–982. doi:10.1248/cpb.58.980.
   PubMed Web of Science ®Google Scholar
• Commission E Monographs. 1984. Visci albi herba. Available from: http://buecher.heilpflanzen-welt.de/BGA-Commission-E-Monographs/0255.htm.
   Google Scholar
• Delebinski CI, Jaeger S, Kemnitz-Hassanin K, Henze G, Lode HN, Seifert GJ. 2012. A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia. Cell Prolif. 45(2):176–187. doi:10.1111/j.1365-2184.2011.00801.x.
   PubMed Web of Science ®Google Scholar
• Deliorman D, Çalı¸ İ, Ergun F, Doğan BS, Buharalıoğlu CK, Kanzık İ. 2000. Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp. album. J Ethnopharmacol. 72(1–2):323–329. doi:10.1016/S0378-8741(00)00251-8.
   PubMed Web of Science ®Google Scholar
• Deliorman D, Çali¸ I, Ergun F, Tamer U. 1999. The comparative studies on phenylpropanoid glycosides of Viscum album subspecies by high performance liquid chromatography. J Liquid Chromatogr Relat Technol. 22(20):3101–3114. doi:10.1081/JLC-100102078.
   Web of Science ®Google Scholar
• Deliorman D, Ergun F, Şener B, Palittapongarnpim P. 2001. Evaluation of antimycobacterial activity of Viscum album subspecies. Pharm Biol. 39(5):381–383. doi:10.1076/phbi.39.5.381.5900.
   Web of Science ®Google Scholar
• Deliorman Orhan D, Çalis İ, Ergun F. 2002. Two new flavonoid glycosides from Viscum album ssp. album. Pharm Biol. 40(5):380–383. doi:10.1076/phbi.40.5.380.8460.
   Web of Science ®Google Scholar
• Deliorman Orhan D, Küpeli E, Yesilada E, Ergun F. 2006. Anti-inflammatory and antinociceptive activity of flavonoids isolated from Viscum album ssp. album. Zeitschrift für Naturforschung. 61c:26–30.
   Google Scholar
• Duong Van Huyen J-P, Delignat S, Bayry J, Kazatchkine MD, Bruneval P, Nicoletti A, Kaveri SV. 2006. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. Cancer Lett. 243(1):32–37. doi:10.1016/j.canlet.2005.11.016.
   PubMed Web of Science ®Google Scholar
• Edler L. 2004. Mistel in Krebstherapie. Fragwürdige Ergebnisse neuerer klinischer Studien [Mistletoe in cancer therapy. Questionable results of new clinical studies]. Deutsches Ärzteblatt. 101:A44–A49.
   Google Scholar
• Effiong OO, Udo NV, Monday EN. 2014. Reduction in serum bilirubin concentration following administration of crude leaf extract of Viscum album (mistletoe) in high salt fed rats. Br J Pharm Res. 4(3):352–361. doi:10.9734/BJPR/2014/7359.
   Google Scholar
• Elluru SR, Duong van Huyen JP, Delignat S, Prost F, Heudes D, Kazatchkine MD, Friboulet A, Kaveri SV. 2009. Antiangiogenic properties of Viscum album extracts are associated with endothelial cytotoxicity. Anticancer Res. 29:2945–2950.
   PubMed Web of Science ®Google Scholar
• Ernst E. 2002. Cancer therapy with mistletoe: hope or hype? J Herb Pharmacother. 2:3–5.
   PubMedGoogle Scholar
• Ernst E, Schmidt K, Steuer-Vogt K. 2003. Mistletoe for cancer?. Int J Cancer. 107(2):262–267. doi:10.1002/ijc.11386.
   PubMed Web of Science ®Google Scholar
• Ertürk Ö, Kati H, Yayli N, Demirbağ Z. 2003. Antimicrobial activity of Viscum album L. subsp. abietis (Wiesb). Turk J Biol. 27:255–258.
   Google Scholar
• Franz H. 1985. Inhaltsstoffe der Mistel (Viscum album L.) als potentielle Arzneimittel [The components of mistletoe (Viscum album) as potential drugs]. Pharmazie. 40:97–104.
   PubMed Web of Science ®Google Scholar
• Fukunaga T, Kajikawa I, Nishiya K, Watanabe Y, Takeya K, Itokawa H. 1987. Studies on the constituents of the European mistletoe, Viscum album L. Chem Pharm Bull. 35(8):3292–3297. doi:10.1248/cpb.35.3292.
   Web of Science ®Google Scholar
• Gardin NE. 2009. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series. Phytother Res. 23(3):407–411. doi:10.1002/ptr.2643.
   PubMed Web of Science ®Google Scholar
• Gray AM, Flatt PR. 1999. Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J Endocrinol. 160(3):409–414. doi:10.1677/joe.0.1600409.
   PubMed Web of Science ®Google Scholar
• Gupta G, Kazmi I, Afzal M, Rahman M, Saleem S, Ashraf MS, Khusroo MJ, Nazeer K, Ahmed S, Mujeeb M, et al. 2012. Sedative, antiepileptic and antipsychotic effects of Viscum album L. (Loranthaceae) in mice and rats. J Ethnopharmacol. 141(3):810–816. doi:10.1016/j.jep.2012.03.013.
   PubMed Web of Science ®Google Scholar
• Haas K, Bauer M, Wollenweber E. 2003. Cuticular waxes and flavonol aglycones of mistletoes. Zeitschrift für Naturforschung. 58c:464–470.
   Google Scholar
• Hajtó T, Fodor K, Perjési P, Németh P. 2011. Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine. Evid Based Complement Altern Med. 2011:1–6. ID 298972. 10.1093/ecam/nep191.
   Google Scholar
• Hegde P, Maddur MS, Friboulet A, Bayry J, Kaveri SV, Zimmer J. 2011. Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2. PLoS ONE. 6(10):e26312. doi:10.1371/journal.pone.0026312.
   Google Scholar
• Hegnauer R. 1966. Chemotaxonomie der Pflanzen [Chemosystematics of plants]. Vol. 4. Basel: BirkhäuserVerlag.
   Google Scholar
• Horneber M, Bueschel G, Huber R, Linde K, Rostock M. 2008. Mistletoe therapy in oncology (review). The Cochrane Collaboration. Vol. 2, p. 1–92. Wiley. Available from: http.://www.thecochranelibrary.com.
   Google Scholar
• Jäger S, Winkler K, Pfüller U, Scheffler A. 2007. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med. 73:157–162.
   PubMed Web of Science ®Google Scholar
• Jordan E, Wagner H. 1986. Structure and properties of polysaccharides from Viscum album (L.). Oncology. 43(1):8–15. doi:10.1159/000226414.
   PubMed Web of Science ®Google Scholar
• Jurin M, Zarković N, Hrženjak M, Ilić Z. 1993. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel. Oncology. 50(6):393–398. doi:10.1159/000227217.
   PubMed Web of Science ®Google Scholar
• Karagöz A, Önay E, Arda N, Kuru A. 2003. Antiviral potency of mistletoe (Viscum album ssp. album) extracts against human parainfluenza virus type 2 in Vero cells. Phytother Res. 17:560–562.
   PubMed Web of Science ®Google Scholar
• Kienle GS, Berrino F, Büssing A, Portalupi E, Rosenzweig S, Kiene H. 2003. Mistletoe in cancer. A systematic review on controlled clinical trials. Eur J Med Res. 8:109–119.
   PubMed Web of Science ®Google Scholar
• Kienle GS, Glockmann A, Schink M, Kiene H. 2009. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res. 28(1):79. doi:10.1186/1756-9966-28-79.
   PubMed Web of Science ®Google Scholar
• Kienle GS, Grugel R, Kiene H. 2011. Safety of higher dosages of Viscum album L. in animals and humans – systematic review of immune changes and safety parameters. BMC Complement Altern Med. 11(1):72. doi:10.1186/1472-6882-11-72.
   PubMed Web of Science ®Google Scholar
• Kienle GS, Kiene H. 2010. Influence of Viscum album L. (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther. 9(2):142–157. doi:10.1177/1534735410369673.
   PubMed Web of Science ®Google Scholar
• Liu B, Bian H-J, Bao J-K. 2010. Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett. 287(1):1–12. doi:10.1016/j.canlet.2009.05.013.
   PubMed Web of Science ®Google Scholar
• Łuczkiwicz M, Cisowski W, Kaisner P, Ochocka R, Piotrowski A. 2001. Comparative analysis of phenolic acids in mistletoe plants from various hosts. Acta Pol Pharm Drug Res. 58:373–379.
   PubMedGoogle Scholar
• Martin Cordero C, Gil Serrano AM, Ayuso Gonzalez MJ. 1993. Transfer of bipiperidyl and quinolizidine alkaloids to Viscum cruciatum Sieber (Loranthaceae) hemiparasitic on Retama sphaerocarpa Boissier (Leguminosae). J Chem Ecol. 19(10):2389–2393. doi:10.1007/BF00979672.
   PubMed Web of Science ®Google Scholar
• Marvibaigi M, Supriyanto E, Amini N, Abdul Majid FA, Jaganathan SK. 2014. Preclinical and clinical effects of mistletoe against breast cancer. BioMed Res Int. 2014:1–15. ID 785479. 10.1155/2014/785479.
   Web of Science ®Google Scholar
• Melzer J, Iten F, Hostanska K, Saller R. 2009. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. Forschende Komplementärmedicin. 16:217–226.
   Web of Science ®Google Scholar
• Nhiem NX, Lee HY, Kim NY, Park SJ, Kim ES, Han JE, Yang H, Kim SH. 2012. Stereochemical assignment of five new lignan glycosides from Viscum album by NMR study combined with CD spectroscopy. Magn Reson Chem. 50(11):772–777. doi:10.1002/mrc.3875.
   PubMed Web of Science ®Google Scholar
• Ofem OE, Eno AE, Imoru J, Nkanu E, Unoh F, Ibu JO. 2007. Effect of crude aqueous leaf extract of Viscum album (mistletoe) in hypertensive rats. Indian J Pharmacol. 39(1):15–19. doi:10.4103/0253-7613.30756.
   Web of Science ®Google Scholar
• Ohiri FC, Esimone CO, Nwafor SV, Okoli CO, Ndu OO. 2003. Hypoglycemic properties of Viscum album (mistletoe) in alloxan-induced diabetic animals. Pharm Biol. 41(3):184–187. doi:10.1076/phbi.41.3.184.15098.
   Web of Science ®Google Scholar
• Önay-Uçar E, Karagöz A, Arda N. 2006. Antioxidant activity of Viscum album ssp. album. Fitoterapia. 77:556–560.
   PubMed Web of Science ®Google Scholar
• Panossian A, Kocharian A, Matinian K, Amroyan E, Gabrielian E, Mayr Chr, Wagner H. 1998. Pharmacological activity of phenylpropanoids of the mistletoe, Viscum album L., host: Pyrus caucasica Fed. Phytomedicine. 5(1):11–17. doi:10.1016/S0944-7113(98)80053-6.
   PubMed Web of Science ®Google Scholar
• Park J-H, Hyun C-K, Shin H-K. 1999. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album). Cancer Lett. 139(2):207–213. doi:10.1016/S0304-3835(99)00043-9.
   PubMed Web of Science ®Google Scholar
• Peumans WJ, Verhaert P, Pfüller U, Van Damme EJM. 1996. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album). FEBS Lett. 396(2–3):261–265. doi:10.1016/0014-5793(96)01108-8.
   PubMed Web of Science ®Google Scholar
• Pfüller U. 2004. Chemical constituents of European mistletoe (Viscum album L.) isolation and characterization of the main relevant ingredients: lectins, viscotoxins, oligo-/polysaccharides, flavonoides, alkaloids. In: Büssing A, editor. Mistletoe. The genus Viscum. Amsterdam: Taylor & Francis e-Library; p. 101–122.
   Google Scholar
• Radenkovic M, Ivetic V, Popovic M, Brankovic S, Gvozdenovic I. 2009. Effects of mistletoe (Viscum album L., Loranthaceae) extracts on arterial blood pressure in rats treated with atropine sulfate and hexocycline. Clin Exp Hypertens. 31(1):11–19. doi:10.1080/10641960802409820.
   PubMed Web of Science ®Google Scholar
• Ribéreau-Gayon G, Dumont S, Muller C, Jung M-L, Poindron P, Anton R. 1996. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett. 109(1–2):33–38. doi:10.1016/S0304-3835(96)04401-1.
   Google Scholar
• Rote Liste. 2011. Arzneimittelverzeichnis für Deutschland [Register of drugs in Germany]. Frankfurt/Main: Verlag Rote Liste® Service GmbH.
   Google Scholar
• Schaller G, Urech K, Giannattasio M. 1996. Cytotoxicity of different viscotoxins and extracts from the European subspecies of Viscum album L. Phytother Res. 10(6):473–477. doi:10.1002/(SICI)1099-1573(199609)10:6 < 473:AID-PTR879>3.0.CO;2-Q.
   Web of Science ®Google Scholar
• Schaller G, Urech K, Grazi G, Giannattasio M. 1998. Viscotoxin composition of the three European subspecies of Viscum album. Planta Med. 64(7):677–678. doi:10.1055/s-2006-957553.
   PubMed Web of Science ®Google Scholar
• Shahaboddin ME, Pouramir M, Moghadamnia A-A, Lakzaei M, Mirhashemi SM, Motallebi M. 2011. Antihyperglycemic and antioxidant activity of Viscum album extract. Afr J Pharm Pharmacol. 5(3):433–436. doi:10.5897/AJPP11.136.
   Google Scholar
• Simon MM, Simard JC, Girard D. 2013. Viscum album agglutinin-I (VAA-I) increases cell surface expression of cytoskeletal proteins in apoptotic human neutrophils: moesin and ezrin are two novel targets of VAA-I. Hum Exp Toxicol. 32(10):1097–1106. doi:10.1177/0960327112468910.
   PubMed Web of Science ®Google Scholar
• Skidmore-Roth L. 2004. Mosby's handbook of herbs and natural supplements. St Louis, MO: Mosby; p. 663.
   Google Scholar
• Strüh CM, Jäger S, Schempp CM, Scheffler A, Martin SF. 2012. A novel triterpene extract from mistletoe induces rapid apoptosis in murine B16.F10 melanoma cells. Phytother Res. 26:1507–1512.
   PubMed Web of Science ®Google Scholar
• Tröger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M. 2013. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer. 49:3788–3797.
   PubMed Web of Science ®Google Scholar
• Tusenius KJ, Spoek AM, van Hattum J. 2005. Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. Arzneimittelforschung. 55:749–753.
   PubMed Web of Science ®Google Scholar
• Vica¸ SI, Rugină D, Leopold L, Pintea A, Socaciu C. 2011. HPLC fingerprint of bioactive compounds and antioxidant activities of Viscum album from different host trees. Notulae Botanicae Horti Agrobotanici Cluj-Napoca. 39:48–57.
   Web of Science ®Google Scholar
• Vica¸ SI, Rugina D, Socaciu C. 2012. Antioxidant activity of European mistletoe (Viscum album). In: Rao W, editor. Phytochemicals as nutriceuticals – global approches to their role in nutrition and health; p. 115–134.
   Google Scholar
• Wacker R, Stoeva S, Pfüller K, Pfüller U, Voelter W. 2004. Complete structure determination of the A chain of mistletoe lectin III from Viscum album L. ssp. album. J Pept Sci. 10(3):138–148. doi:10.1002/psc.505.
   PubMed Web of Science ®Google Scholar
• Wagner H, Feil B, Seligmann O, Petricic J, Kalogjera Z. 1986. Phenylpropanes and lignans of Viscum album. Cardioactive drugs V. Planta Med. 52(2):102–104.
   Google Scholar
• Werthmann PG, Sträter G, Friesland H, Kienle GS. 2013. Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts – a case report. Phytomedicine. 20(3–4):324–327. doi:10.1016/j.phymed.2012.11.001.
   PubMed Web of Science ®Google Scholar
• Wichtl M, ed. 2004. Herbal drugs and phytopharmaceuticals. Stuttgart: Medpharm.
   Google Scholar